All posts
-
Nestlé bets big on AI and biotech with new deep tech center in Switzerland
A brand-new deep technology facility at Nestlé’s System Innovation Facility in Orbe, Switzerland, will certainly open up following year to increase the food and nourishment t…
-
Shroom boom: Fable Food’s mushroom-forward approach pays off as alt meat struggles
[Disclosure: AFN’s parent company, AgFunder, is an investor in Fable Food.] Sydney-based Fable Food scratched up 50%+ year-over-year development in 2014 with its “exceptional…
-
Investment in India’s life sciences crawls behind US and China. A new initiative could change that
India stands at a turning point for agrifoodtech investment. With $2.5 billion of agrifoodtech funding in 2024, the country holds an undisputed lead in the developing world, thanks…
-
Robotics for R&D: Validation of innovations, risk mitigation, and accelerated development
R & d (R&D) are the driving pressures behind advancement in basically every commercial and clinical market. In this context, robotics for R&D has actually come to be…
-
Manitoba fires threaten Sinomine’s Tanco lithium-cesium mine
Sinomine’s Tanco mine in southeast Manitoba, among Canada’s 2 lithium mines, deals with threats as wildfires remained to surge in the location on Friday. Tanco, which c…
-
Sanofi to invest USD 20bn in the US
The statement from the French pharmaceutical business comes simply a couple of days after United States Head of state Donald Trump authorized an exec order to make certain consider…
-
For the first time since 2018: Leo Pharma achieves billion-kroner profit in Q1
The big earnings is mostly as a result of the manage US-based Gilead Sciences that Leo Pharma authorized previously this year.
-
Roche reconsiders billion-dollar investments in the US: At risk by decree
The Swiss drugmaker notes threat in Trump’s exec order on medicine rate cuts and intends to reassess financial investments of about USD 50bn in the United States.
-
Despite Trump’s tariff threats on pharma: Lundbeck boss rejects any plans of relocating production
Lundbeck chief executive officer Charl van Zyl is waiting for extra concrete statements from the Trump management on pharmaceutical tolls prior to he can evaluate a prospective eff…
-
Leo Pharma and J&J join AI partnership funded by Innovation Fund Denmark
Development Fund Denmark has actually granted DKK 12.1 m to an AI collaboration called EVA to create an AI engine to enhance clinical therapies and spot negative effects much faste…
